Combined cisplatin and aurora inhibitor treatment increase neuroblastoma cell death but surviving cells overproduce BDNF.

Polacchini, Alessio; Albani, Clara; Baj, Gabriele; Colliva, Andrea; Carpinelli, Patrizia; Tongiorgi, Enrico

Polacchini, Alessio; Albani, Clara; Baj, Gabriele; Colliva, Andrea; Carpinelli, Patrizia; Tongiorgi, Enrico.

Afiliação

Polacchini A; University of Trieste, Department of Life Sciences, Trieste 34127, Italy.
Albani C; University of Trieste, Department of Life Sciences, Trieste 34127, Italy Nerviano Medical Sciences, Nerviano, Milano 20014, Italy Department of Drug Discovery and Development, Istituto Italiano di Tecnologia, Genova 16163, Italy.
Baj G; University of Trieste, Department of Life Sciences, Trieste 34127, Italy.
Colliva A; University of Trieste, Department of Life Sciences, Trieste 34127, Italy.
Carpinelli P; Nerviano Medical Sciences, Nerviano, Milano 20014, Italy.
Tongiorgi E; University of Trieste, Department of Life Sciences, Trieste 34127, Italy tongi@units.it.

Biol Open ; 5(7): 899-907, 2016 Jul 15.

Article em En | MEDLINE | ID: mdl-27256407

Palavras-chave

Aurora kinase; Cisplatin; Drug resistance; Neuroblastoma; Neurotrophins; PHA-680632

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Biol Open Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Itália

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google